Gitnux/Report 2026

Cell Culture Industry Statistics

The global cell culture market reached $21.0 billion in 2026, explore the figures behind growth, companies and trends.
15Statistics
22Sources
3Sections
14mRead
Cell Culture Industry Statistics
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The cell culture industry at a glance

The global cell culture market is estimated at $21.0 billion in 2026, with demand driven by biopharmaceutical manufacturing, cell and gene therapy, and cell-based drug research.

$21.0B[3]
Global market size, 2026
12.9%[3]
Forecast CAGR, 2026–2033
36.05%[3]
North America share, 2025
$3.96B[9]
Cell culture media market, 2030
Market size
Grand View Research estimates the global cell culture market at $19.1 billion in 2025 and $21.0 billion in 2026. A separate estimate from Mordor Intelligence values the 2025 market at $29.34 billion, reflecting differences in market definitions and coverage.[3][1]
Forecast & CAGR
Grand View Research forecasts growth from $21.0 billion in 2026 to $49.3 billion in 2033, representing a 12.9% CAGR. MarketsandMarkets projects a lower 11.2% CAGR from 2025 to 2030, reaching $50.69 billion.[3][10]
Market share & regions
North America accounted for 36.05% of the global cell culture market in 2025 according to Grand View Research. In the narrower cell culture media and cell lines segment, North America held 43.15% in 2025.[3]
Segmentation
The market is commonly segmented by product into consumables and instruments, and by application into biopharmaceutical production, drug development, tissue engineering, cell and gene therapy, and toxicity testing. Other published classifications segment by cell type, including primary cultures, secondary cultures, and established cell lines, and by media type, including natural and artificial media.[3][2]
Key players & concentration
Major suppliers include Thermo Fisher Scientific, Merck, Danaher, Sartorius, and Becton Dickinson, but reliable public data identifying a single combined market-share percentage for the overall cell culture industry was not found. The market is fragmented across media, reagents, instruments, cell lines, and services.[3][2]
Pricing
Public catalog prices illustrate the wide range of cell culture input costs: Thermo Fisher lists 10 liters of CD 293 AGT medium at $1,234, 100 liters of OptiPRO medium at $7,580, and 10 kilograms of CD BHK-21 production medium at $3,185. Prices vary by formulation, volume, grade, and customization.[11]
Trends, drivers & challenges
Growth is being supported by biopharmaceutical production, personalized medicine, cell and gene therapy, and increasing use of cell-based assays in drug discovery. Key challenges include serum and raw-material variability, complex culture conditions, contamination control, scalability, and the high cost of manufacturing-grade inputs.[3][11]
Consumer behavior & competition
End-user demand is concentrated among pharmaceutical and biotechnology companies, academic and research institutes, hospitals, diagnostic laboratories, and cell banks. Competition is increasingly based on reproducibility, defined and serum-free formulations, automation, supply reliability, and compatibility with cell and gene therapy manufacturing rather than on price alone.[2][11]
M&A
Cell culture suppliers compete within a broader life-sciences M&A environment: Deloitte reported $120 billion in life-sciences deals in 2025, with oncology accounting for 30% of deal value, including interest in immune-cell therapies. Publicly documented figures isolating M&A activity for the cell culture industry itself were not found.[12]
Regulation
In May 2026, the U.S. FDA issued guidance describing CMC flexibilities for human cellular and gene therapy products developed for biologics license applications under 21 CFR Part 601. In November 2026, FDA issued final potency-assurance guidance covering cell and gene therapy products from early development through post-approval monitoring.[13]
Latest news
The latest major regulatory development identified was FDA's November 2, 2026 final guidance on potency assurance for cellular and gene therapy products. The guidance recommends a risk-based strategy covering raw-material variability, manufacturing tests, batch potency, short shelf-life products, viral vectors, and patient-specific therapies.[13]

02 Ranking

Top 10 Companies in the Cell Culture Industry

The leading companies in the cell culture industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Lonza stands out for mammalian cell culture development and manufacturing because it provides mammalian cell culture development, manufacturing and media technologies, while Corning focuses on cell culture consumables since it supplies cell culture vessels, surfaces and laboratory tools worldwide.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in mammalian cell culture CDMO

    Lonza

    CH

    Ranked #1 · 9.3 · Mammalian cell culture CDMO

    Why we picked it: It provides development and manufacturing services tied to mammalian cell culture and media technologies, alongside an an 19% operating margin.

  2. Leader in cell culture consumables

    Corning

    US

    Ranked #2 · 9.3 · Cell culture consumables

    Why we picked it: Its consumables focus includes cell culture vessels and surfaces, supported by an an 14.6% operating margin.

  3. Leader in cell culture media & instruments

    Thermo Fisher Scientific

    US

    Ranked #3 · 9.0 · Cell culture media & instruments

    Why we picked it: It spans media, sera, vessels, reagents, and instruments, with an 17.4% operating margin.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the cell culture industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Lonza

Mammalian cell culture CDMO · CH

9.3
2

Corning

Cell culture consumables · US

9.3
3

Thermo Fisher Scientific

Cell culture media & instruments · US

9.0
4

Sartorius

Cell cultivation systems · DE

9.0
5

STEMCELL Technologies

Primary cells & specialty media · CA

8.9
6

FUJIFILM Holdings

Cell culture biomanufacturing and bioprocessing · JP

8.7
7

PromoCell

Primary cells and customized cell culture media · DE

8.3
8

Bio-Rad Laboratories

Cell culture reagents and bioprocess analytics · US

8.0
9

HiMedia Laboratories

Cell culture media and microbiology reagents · IN

7.7
10

Eppendorf

Cell culture equipment, vessels and consumables · DE

7.7

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the cell culture industry. In Cell Culture Industry Statistics. Gitnux. https://gitnux.org/cell-culture-industry-statistics/#top-companies

04 Statistics

Market Intelligence

Market-intelligence figures show both definitional variation and a 2026-to-2033 growth path from $21.0 billion to $49.3 billion at a 12.9% CAGR.

Market size, volume and shipments in the cell culture industry

  • USD 29.34 billion was the global cell culture market size in 2025, measured across product, cell type, technology, application, end-user and geography segments.[1]
  • USD 31.25 billion was the global cell culture market size in 2025, covering primary and secondary cultures, cell lines, media and applications including biopharmaceuticals, according to The Business Research Company.[2]
  • USD 19.1 billion was the global cell culture market size in 2025, covering consumables and instruments across biopharmaceutical production, drug development, tissue engineering, cell and gene therapy, and toxicity testing.[3]

Forecast growth and shipments in the cell culture industry

  • The global cell culture market is forecast to reach USD 46.73 billion in 2030 from USD 33.81 billion in 2026, implying an 8.4% CAGR; the report was published for the 2026–2030 forecast period.[2]
  • The global cell culture market is projected to reach USD 49.3 billion in 2033 from USD 21.0 billion in 2026, at a 12.9% CAGR; the forecast was published in 2026.[3]
  • The global cell culture market is projected to reach USD 58.42 billion in 2031 from USD 33.07 billion in 2026, at a 12.1% CAGR; the forecast was published in June 2026.[4]

Regional split of the cell culture industry

  • North America accounted for 36.05% of global cell culture market revenue in 2025, the largest regional share in Grand View Research’s geography-defined market model.[3]
  • In 2025, North America represented 39.8%, Europe 27.4%, Asia-Pacific 24.6%, and LAMEA 8.2% of global cell culture market revenue.[5]
  • North America held 35.59% of global cell culture market revenue in 2025, while Asia-Pacific is forecast to grow at 9.27% annually from 2026 to 2031.[1]

05 Statistics

Strategy & Growth

Strategy and growth highlights scale expansion: Fujifilm Diosynth Biotechnologies planned 8 × 20,000-litre mammalian cell-culture bioreactors in 2028.

Capacity expansion in the cell culture industry

  • $1.2 billion was announced in 2024 for an additional 8 × 20,000-litre mammalian cell-culture bioreactors at Fujifilm Diosynth Biotechnologies’ Holly Springs, North Carolina, site, planned for 2028.[6]
  • The first phase opened in 2025 with 8 × 20,000-litre mammalian cell-culture bioreactors; the planned second phase increases the site to 16 bioreactors.[6]
  • The Holly Springs expansion includes approximately 400,000 square feet of additional manufacturing space and 8 × 20,000-litre cell-culture bioreactors, with completion planned by 2028.[7]

06 Statistics

Trade & Footprint

Trade and footprint focuses attention on cross-border flows: in 2024, U.S. exports under HS 3002.51 reached $768.7 million and 303,098 kg.

Imports and exports of cell culture

  • U.S. imports of cell cultures, whether or not modified, under HS 3002.51 were $33.4 million and 4,025 kg in 2024.[8]
  • U.S. exports of cell cultures, whether or not modified, under HS 3002.51 were $768.7 million and 303,098 kg in 2024.[8]
  • U.S. re-exports of cell cultures, whether or not modified, under HS 3002.51 were $9.4 million and 6,625 kg in 2024.[8]

Key questions about the cell culture industry

How large is the global cell culture market in 2026?
The global cell culture market is estimated at $21.0 billion in 2026, driven by biopharmaceutical manufacturing, cell and gene therapy, and cell-based drug research.
What growth rate is expected for the market after 2026?
Grand View Research forecasts growth from $21.0 billion in 2026 to $49.3 billion in 2033, a 12.9% CAGR.
Which companies lead the cell culture industry?
Lonza stands out for mammalian cell culture development and manufacturing because it provides mammalian cell culture development, manufacturing and media technologies, while Corning focuses on cell culture consumables since it supplies cell culture vessels, surfaces and laboratory tools worldwide.
Which technology shifts matter most for cell culture purchasing?
Serum-free media gains share and animal-origin-free inputs become standard. Potency testing moves upstream, while automation reduces manual handling and closed systems gain manufacturing share.
How is the cell culture industry structured in public data?
The market is fragmented across media, reagents, instruments, cell lines, and services, with no reliable public data for a single combined market-share percentage for the overall industry.
What do U.S. trade flows show for cell cultures in 2024?
In 2024, U.S. imports under HS 3002.51 were $33.4 million and 4,025 kg, while exports were $768.7 million and 303,098 kg.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Cell Culture Industry Statistics. Gitnux. https://gitnux.org/cell-culture-industry-statistics
MLA
Samuel Norberg. "Cell Culture Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/cell-culture-industry-statistics.
Chicago
Samuel Norberg. 2026. "Cell Culture Industry Statistics." Gitnux. https://gitnux.org/cell-culture-industry-statistics.